Followers | 9 |
Posts | 750 |
Boards Moderated | 0 |
Alias Born | 10/19/2008 |
Tuesday, August 25, 2015 11:27:27 AM
While I wish share prices had not reached these levels, I also think these lower share prices and the overall market volatility, could actually help force company focus and milestone attainment.
In this environment it will be harder for them to raise new cash at a good deal like they have been able to do so far. The biggest disappointment I have had with NNVC’s development progress is the missing of stated timelines, often by their shifting of gears as a result of contemporary viral infection outbreaks or other distractors. Other distractors that were actually good test results on other viral types!
What is remarkable, regardless of the timeline, is what they have achieved with the total investment so far. NNVC is actually close to the best in the biotech industry at developing therapeutics with such good efficacy results at the lowest absolute cost of development overall. Yet, distractors have added up and blurred product development focus.
In an environment like we are entering for NNVC and the markets in general they may need to take what they have, still about 2 years funding on hand, make sure they have a stable path forward. This is the first time something I would have called a distractor once again, the anti-herpesvirus work, is now a plus. I had hoped they took this path earlier. It may prove to be a great financial stabilizer for the company. I suspect this could also be pushed a little by Dr. Boniuk on the BOD and potentially why he is such a big insider buyer.
Topical therapeutics are indeed far far far more easily brought to market. 90% or more less red tape to start with! If suitable, they should look for a partner to produce the creams and other carriers, to allow getting to the market as soon as possible. That would give them some revenues to fund expansion and development, plus good experience as well. It would also bring back investor confidence in that we would start to see a business taking shape underneath the great potential the Nanovircides have to offer.
Best of luck to all. A good friend’s wife just passed away from ovarian cancer. It was not a good scene. Enjoy every day and every moment you can. In the end, it is not the investment gains one made, or objects they acquired that hold any true value. All we really have is the present and all that really matters is our feelings. Regardless of what you think about NNVC, I am glad there are people out there that try to develop products that help reduce suffering. Which is better, to develop a drug that doesn’t make it or a phone app that doesn’t make it, or ones that do and/or show the way.
HS
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM